MENU
+Compare
LGHT
ETF ticker: NYSE ARCA
AS OF
Jan 14 closing price
Price
$10.32
Change
+$0.03 (+0.29%)
Net Assets
4.12M

LGHT stock forecast, quote, news & analysis

The investment seeks long-term growth of capital... Show more

Category: #Health
LGHT
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for LGHT with price predictions
Jan 13, 2026

LGHT in downward trend: price expected to drop as it breaks its higher Bollinger Band on January 05, 2026

LGHT broke above its upper Bollinger Band on January 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 12 similar instances where the stock broke above the upper band. In of the 12 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for LGHT moved out of overbought territory on January 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator moved out of overbought territory. In of the 7 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LGHT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 23, 2025. You may want to consider a long position or call options on LGHT as a result. In of 36 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LGHT just turned positive on December 22, 2025. Looking at past instances where LGHT's MACD turned positive, the stock continued to rise in of 18 cases over the following month. The odds of a continued upward trend are .

LGHT moved above its 50-day moving average on January 05, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LGHT crossed bullishly above the 50-day moving average on January 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LGHT advanced for three days, in of 78 cases, the price rose further within the following month. The odds of a continued upward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), IQVIA Holdings (NYSE:IQV), Moderna (NASDAQ:MRNA), Align Technology (NASDAQ:ALGN), Teladoc Health (NYSE:TDOC).

Industry description

The investment seeks long-term growth of capital. Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization. The fund is non-diversified.

Market Cap

The average market capitalization across the Langar Global HealthTech ETF ETF is 19.93B. The market cap for tickers in the group ranges from 329.45M to 193.82B. ISRG holds the highest valuation in this group at 193.82B. The lowest valued company is TBRG at 329.45M.

High and low price notable news

The average weekly price growth across all stocks in the Langar Global HealthTech ETF ETF was 13%. For the same ETF, the average monthly price growth was 36%, and the average quarterly price growth was 89%. MRNA experienced the highest price growth at 13%, while DOCS experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Langar Global HealthTech ETF ETF was 4%. For the same stocks of the ETF, the average monthly volume growth was 22% and the average quarterly volume growth was 54%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 62
Price Growth Rating: 53
SMR Rating: 73
Profit Risk Rating: 91
Seasonality Score: 12 (-100 ... +100)
View a ticker or compare two or three
LGHT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
116 South Franklin StreetP. O. Box 69Rocky Mount
Phone
252-972-9922
Web
N/A